Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Feb;82(4):823–826. doi: 10.1054/bjoc.1999.1006

Mutation analysis of P73 and TP53 in Merkel cell carcinoma

M Van Gele 1, M Kaghad 6, J H Leonard 5, N Van Roy 1, J M Naeyaert 2, M L Geerts 2, S Van Belle 3, V Cocquyt 3, J Bridge 7, R Sciot 4, C De Wolf-Peeters 4, A De Paepe 1, D Caput 6, F Speleman 1
PMCID: PMC2374386  PMID: 10732753

Abstract

The p73 gene has been mapped to 1p36.33, a region which is frequently deleted in a wide variety of neoplasms including tumours of neuroectodermal origin. The p73 protein shows structural and functional homology to p53. For these reasons, p73 was considered as a positional and functional candidate tumour suppressor gene. Thus far, mutation analysis has provided no evidence for involvement of p73 in oligodendrogliomas, lung carcinoma, oesophageal carcinoma, prostatic carcinoma and hepatocellular carcinoma. In neuroblastoma, two mutations have been observed in a series of 140 tumours. In view of the occurrence of 1p deletions in Merkel cell carcinoma (MCC) and the location of p73 we decided to search for mutations in the p73 gene in five MCC cell lines and ten MCC tumours to test potential tumour suppressor function for this gene in MCC. In view of the possible complementary functions of p73 and TP53 we also examined the status of the TP53 gene. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in four MCCs. In one MCC tumour, a mis-sense mutation located in the NH2-terminal transactivation region of the p73 gene was found. These results show that p73, analogous to neuroblastoma, is infrequently mutated in MCC. This is also the first report in which the role of TP53 in MCC has been investigated by sequencing the entire coding region of TP53. TP53 mis-sense mutations and one non-sense mutation were detected in three of 15 examined MCCs, suggesting that TP53 mutations may play a role in the pathogenesis or progression of a subset of MCCs. Moreover, typical UVB induced C to T mutations were found in one MCC cell line thus providing further evidence for sun-exposure in the aetiology of this rare skin cancer. © 2000 Cancer Research Campaign

Keywords: Merkel cell carcinoma, 1p36;p73;TP53, mutation

Full Text

The Full Text of this article is available as a PDF (121.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brash D. E., Rudolph J. A., Simon J. A., Lin A., McKenna G. J., Baden H. P., Halperin A. J., Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124–10128. doi: 10.1073/pnas.88.22.10124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994 Jul 15;265(5170):346–355. doi: 10.1126/science.8023157. [DOI] [PubMed] [Google Scholar]
  3. Ichimiya S., Nimura Y., Kageyama H., Takada N., Sunahara M., Shishikura T., Nakamura Y., Sakiyama S., Seki N., Ohira M. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene. 1999 Jan 28;18(4):1061–1066. doi: 10.1038/sj.onc.1202390. [DOI] [PubMed] [Google Scholar]
  4. Jost C. A., Marin M. C., Kaelin W. G., Jr p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997 Sep 11;389(6647):191–194. doi: 10.1038/38298. [DOI] [PubMed] [Google Scholar]
  5. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997 Aug 22;90(4):809–819. doi: 10.1016/s0092-8674(00)80540-1. [DOI] [PubMed] [Google Scholar]
  6. Kovalev S., Marchenko N., Swendeman S., LaQuaglia M., Moll U. M. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 1998 Nov;9(11):897–903. [PubMed] [Google Scholar]
  7. Mai M., Huang H., Reed C., Qian C., Smith J. S., Alderete B., Jenkins R., Smith D. I., Liu W. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics. 1998 Aug 1;51(3):359–363. doi: 10.1006/geno.1998.5387. [DOI] [PubMed] [Google Scholar]
  8. Mai M., Yokomizo A., Qian C., Yang P., Tindall D. J., Smith D. I., Liu W. Activation of p73 silent allele in lung cancer. Cancer Res. 1998 Jun 1;58(11):2347–2349. [PubMed] [Google Scholar]
  9. Mihara M., Nimura Y., Ichimiya S., Sakiyama S., Kajikawa S., Adachi W., Amano J., Nakagawara A. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br J Cancer. 1999 Jan;79(1):164–167. doi: 10.1038/sj.bjc.6690027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nimura Y., Mihara M., Ichimiya S., Sakiyama S., Seki N., Ohira M., Nomura N., Fujimori M., Adachi W., Amano J. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer. 1998 Nov 9;78(4):437–440. doi: 10.1002/(sici)1097-0215(19981109)78:4<437::aid-ijc8>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Nomoto S., Haruki N., Kondo M., Konishi H., Takahashi T., Takahashi T., Takahashi T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 1998 Apr 1;58(7):1380–1383. [PubMed] [Google Scholar]
  12. Ratner D., Nelson B. R., Brown M. D., Johnson T. M. Merkel cell carcinoma. J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):143–156. doi: 10.1016/0190-9622(93)70159-q. [DOI] [PubMed] [Google Scholar]
  13. Schmid M., Janssen K., Dockhorn-Dworniczak B., Metze D., Zelger B. W., Luger T. A., Schmid K. W. p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch. 1997 Mar;430(3):233–237. doi: 10.1007/BF01324807. [DOI] [PubMed] [Google Scholar]
  14. Schwab M., Praml C., Amler L. C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 1996 Aug;16(4):211–229. doi: 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  15. Sunahara M., Ichimiya S., Nimura Y., Takada N., Sakiyama S., Sato Y., Todo S., Adachi W., Amano J., Nakagawara A. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol. 1998 Aug;13(2):319–323. [PubMed] [Google Scholar]
  16. Takada N., Ozaki T., Ichimiya S., Todo S., Nakagawara A. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 1999 Jun 15;59(12):2810–2814. [PubMed] [Google Scholar]
  17. Takahashi H., Ichimiya S., Nimura Y., Watanabe M., Furusato M., Wakui S., Yatani R., Aizawa S., Nakagawara A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res. 1998 May 15;58(10):2076–2077. [PubMed] [Google Scholar]
  18. Van Gele M., Van Roy N., Ronan S. G., Messiaen L., Vandesompele J., Geerts M. L., Naeyaert J. M., Blennow E., Bar-Am I., Das Gupta T. K. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer. 1998 Sep;23(1):67–71. doi: 10.1002/(sici)1098-2264(199809)23:1<67::aid-gcc10>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  19. Van Roy N., Laureys G., Cheng N. C., Willem P., Opdenakker G., Versteeg R., Speleman F. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer. 1994 Jun;10(2):103–114. doi: 10.1002/gcc.2870100205. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES